drugset / Trial / NCT07067775
Pharmacokinetic/Pharmacodynamic Study of Vicagrel Capsules and Clopidogrel Tablets in Healthy CYP2C19 Normal Metabolizers
RandomizedCrossoverOpen-labelTreatment
Summary
This clinical study will adopt an open-label, randomized, two-crossover design to explore the pharmacokinetic and pharmacodynamic profiles of Vicagrel Capsules and Clopidogrel Tablets in Healthy Subjects with CYP2C19 Normal Metabolizers
Timeline
- Start
- 2025-08-05
- Primary completion
- 2025-08-22
- Completion
- 2025-08-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Clopidogrel | Small molecule | — | — |
| Subject | SUMECIGREL | Small molecule | — | — |